• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
    • Jan 15, 2025Lonza, Iconovo team on intranasal biologic targeting obesity | Aragen secures $100M investment from private equity firm
    Jan 14, 2025Synthego secures license for AstraZeneca’s CRISPR enzyme | ReciBioPharm receives RNA manufacturing grant from Gates Foundation
    Jan 11, 2025Fujifilm Diosynth Biotechnologies expands production at Denmark facility | AGC Biologics teams with Pandorum, adds to Genenta cell therapy partnership
    Jan 10, 2025National Resilience to lay off 120 employees at NC site | Boehringer, Samsung Biologics announce ADC deals
    Jan 9, 2025Ori delivers first IRO platforms to CDMOs, CGT manufacturers | Lifecore sells 10-head isolator filler for $17M
    Jan 8, 2025Sutro, Boehringer achieve large-scale cell-free biomanufacturing | Macsen Labs starts construction on new API manufacturing site
    Jan 7, 2025WuXi Biologics sells Irish vaccine facility to Merck for $500M | Novo Holdings invests in macrocycle manufacturing company
    Jan 4, 2025FDA finalizes advanced manufacturing guidance | Lifecore’s strategy as pure-play CDMO starts to pay off
    Jan 3, 2025Avid’s $1.1B deal to go private appears on track | Roche, Innovent ink potential $1B ADC partnership
    Dec 31, 2024China doubles down on biomanufacturing in 2025 | Vincerx to merge with ADC company Oqory
    Dec 28, 2024Cell and gene therapy sector reaches milestones in 2024, challenges remain
    Dec 27, 2024WuXi AppTec sells Advanced Therapies unit to US firm | India’s Akums inks $200M CDMO pact in Europe
    Dec 24, 2024FDA slaps Viatris with warning letter, import alert | Lonza boosts capsule manufacturing capacity in China, India
    Dec 21, 2024Celltrion challenges Samsung Bioepis in biosimilars | ACG’s massive capsule manufacturing facility
    Dec 20, 2024FDA confirms Lilly’s tirzepatide shortage is resolved | Nirsum selects Lifecore for CDMO services
    Dec 19, 2024Novo Holdings completes $16.5B acquisition of Catalent | Pfizer targets $1.5B in manufacturing reduction costs
    Dec 18, 2024J&J’s Rybrevant filing rejected by FDA over manufacturing issues | Scinai Launches CDMO in US
    Dec 17, 2024Novo Holdings’ $16.5B Catalent acquisition clears regulatory hurdles | Novo Nordisk to build $1.2B rare disease drug factory
    Dec 14, 2024Biopharma groups seek changes to FDA manufacturing strategy | Intertek, CrystecPharma partner on dry powder inhalers
    Dec 13, 2024Lonza restructures to become pure-play CDMO | Vertex, Saudi Arabia collaborate on gene therapy manufacturing
    Dec 12, 2024Daiichi Sankyo invests $152M in ADC plant in China | Cellipont Bioservices, Xiogenix partner on cell therapy manufacturing
    Dec 11, 2024Ori Biotech, Fresenius Kabi team on scalable CGT manufacturing | BioMarin invests $63M in Ireland facility expansion
    Dec 10, 2024Novo-Catalent $16.5B acquisition cleared by EU regulators | BIOSECURE Act left out of US defense budget bill
    Dec 7, 2024Lilly announces $3B expansion in Wisconsin | Lilly, Cambrex team on biotech innovation
    Dec 6, 2024Amgen invests $1B in North Carolina manufacturing expansion | Novo Nordisk begins construction on largest quality control facility in Denmark
    Latest Edition